Ontology highlight
ABSTRACT:
SUBMITTER: De Mattos-Arruda L
PROVIDER: S-EPMC7326255 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
De Mattos-Arruda Leticia L Blanco-Heredia Juan J Aguilar-Gurrieri Carmen C Carrillo Jorge J Blanco Julià J
ESMO open 20200401 Suppl 3
The success of cancer therapies with immune checkpoint inhibitors is transforming the treatment of patients with cancer and fostering cancer research. Therapies that target immune checkpoint inhibitors have shown unprecedented rates of durable long-lasting responses in patients with various cancer types, but only in a fraction of patients. Thus, novel approaches are needed to make immunotherapy more precise and also less toxic. The advances of next-generation sequencing technologies have allowed ...[more]